The Glass Bottles and Vials for Vaccines and Pharmaceutical Market is Expected to grow at a 7.7% CAGR during the forecast period of 2024-2031.
Key Industry Insights & Findings from the Report:
A vial is a small glass or plastic container that stores medication in powders, liquids, and capsules (also referred to as a flacon or phial). The demand for glass bottles and vials has increased due to end users using glass vials more frequently than conventional vials. Since they make recycling simple, they are also eco-friendly. Glass bottles and vials allow producers to lower production costs while providing consumers with items of higher quality. As the demand for pharmaceutical packaging surges, it opens up the potential for marketers to sell the vaccine and pharmaceutical glass bottles and vials. As chances for marketers are created by a rise in demand for pharmaceutical packaging, the glass bottles and vials for vaccines and the pharmaceutical industry are rising. Leading industry players are spending money to improve their market position. A vial maker, SCHOTT AG, recently invested US $333 million in pharmaceutical packaging to grow its glass tubing business. Global market companies are attempting to increase their product offerings and global presence in this industry.
Since the COVID-19 pandemic, the demand for glass bottles and vials used for pharmaceutical and vaccination products has grown exponentially. Following the COVID-19 vaccines' approval, vaccination campaigns have been launched in numerous nations. Due to the enormous demand for glass bottles and vials for vaccine packaging from vaccine makers, the market is expanding. In addition, the market for glass bottles and vials for pharmaceuticals and vaccines will be significantly constrained by the rising cost of the overall packaging.
The Glass Bottles and Vials for Vaccines and Pharmaceutical market is segmented based on application and end-user. Based on application, the market is segmented into vaccines and general medicine. Based on end-user, the glass bottles and vials for vaccines and pharmaceutical is segmented into hospital, drug manufacturers, diagnostic centers and others.
Based on application, the market is segmented into vaccines and general medicine. The vaccine segment dominated the market. Vaccine vials are used in pharmaceutical packaging. The vaccination vial is a compact cylindrical container that can be utilized in industries such as pharmaceutical, medical, environmental, and lab testing. There are several varieties of vaccine vials available, including single dosage and multi-dose vials. Increased investment in glass vaccine vials, particularly in the pharmaceutical industry, increased vaccine production, and rising government initiatives in the biochemical industry are key drivers projected to fuel the growth of the vaccine vials market.
Based on end-user, the glass bottles and vials for vaccines and pharmaceutical is segmented into hospital, drug manufacturers, diagnostic centers and others. The hospital category dominated the market. The need for glass bottles and vials has increased due to their expanding use by hospitals. In hospitals, glass bottles and vials are frequently used to store medications and samples. Over the past ten years, glass bottles and vials have grown in popularity in hospitals because they are non-reactive, have a long shelf life, and are contamination-free.
The North America Glass Bottles and Vials for Vaccines and Pharmaceutical market is expected to register the highest market share in revenue in the near future. Pharmaceutical spending in developing nations is expected to rise in the coming years. With innovative products driving the rise, the United States is projected to be a prominent driver and the region's most important market for expanding the pharmaceutical sector. This expansion is predicted to be aided by an increase in generics in the region, which are expected to maintain high volume and sales demand. In addition, Asia Pacific is projected to grow rapidly in the global Glass Bottles and Vials for Vaccines and Pharmaceutical market. Chronic disease incidence increased healthcare expertise, and rising income levels will help Asia Pacific emerging markets expand. Governments in the Asia Pacific region are expanding their private and public healthcare coverage due to increased knowledge. Government actions in emerging countries to encourage low-cost generic drugs and lower healthcare costs are projected to raise the volume of pharmaceutical products, encouraging the region's market expansion even further.
|
Report Attribute |
Specifications |
|
Growth rate CAGR |
CAGR of 7.7% from 2024 to 2031 |
|
Quantitative units |
Representation of revenue in US$ Million and CAGR from 2024 to 2031 |
|
Historic Year |
2019 to 2023 |
|
Forecast Year |
2024-2031 |
|
Report coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments covered |
Product Type, Crop Type, Application, End-User |
|
Regional scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
|
Competitive Landscape |
SCHOTT AG, Thermo Fisher Scientific, ZHENGCHUAN ICP, Cang Zhou Four-star Glass Co., Ltd, Stevanato Group PIVA, Gerresheimer AG, SGD Pharma, Qorpak, Corning Incorporated and SM PACK. |
|
Customization scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing and available payment methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Glass Bottles and Vials for Vaccines and Pharmaceutical Market Snapshot
Chapter 4. Global Glass Bottles and Vials for Vaccines and Pharmaceutical Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Product Type Estimates & Trend Analysis
5.1. by Product Type & Market Share, 2023 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Product Type:
5.2.1. Less Than 30ml
5.2.2. Between 30ml-80ml
5.2.3. More than 80 ml
Chapter 6. Market Segmentation 2: by Application Estimates & Trend Analysis
6.1. by Application & Market Share, 2023 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Application:
6.2.1. Vaccines
6.2.2. General Medicine
Chapter 7. Market Segmentation 3: by End-user Estimates & Trend Analysis
7.1. by End-user & Market Share, 2023 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by End-user:
7.2.1. Hospital
7.2.2. Drug manufacturers
7.2.3. Diagnostic Centers
7.2.4. Others
Chapter 8. Glass Bottles and Vials for Vaccines and Pharmaceutical Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Glass Bottles and Vials for Vaccines and Pharmaceutical Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2024-2031
8.1.2. North America Glass Bottles and Vials for Vaccines and Pharmaceutical Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
8.1.3. North America Glass Bottles and Vials for Vaccines and Pharmaceutical Market revenue (US$ Million) by End-user, 2024-2031
8.1.4. North America Glass Bottles and Vials for Vaccines and Pharmaceutical Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.2. Europe
8.2.1. Europe Glass Bottles and Vials for Vaccines and Pharmaceutical Market revenue (US$ Million) by Product Type, 2024-2031
8.2.2. Europe Glass Bottles and Vials for Vaccines and Pharmaceutical Market revenue (US$ Million) by Application, 2024-2031
8.2.3. Europe Glass Bottles and Vials for Vaccines and Pharmaceutical Market revenue (US$ Million) by End-user, 2024-2031
8.2.4. Europe Glass Bottles and Vials for Vaccines and Pharmaceutical Market revenue (US$ Million) by country, 2024-2031
8.3. Asia Pacific
8.3.1. Asia Pacific Glass Bottles and Vials for Vaccines and Pharmaceutical Market revenue (US$ Million) by Product Type, 2024-2031
8.3.2. Asia Pacific Glass Bottles and Vials for Vaccines and Pharmaceutical Market revenue (US$ Million) by Application, 2024-2031
8.3.3. Asia-Pacific Glass Bottles and Vials for Vaccines and Pharmaceutical Market revenue (US$ Million) by End-user, 2024-2031
8.3.4. Asia Pacific Glass Bottles and Vials for Vaccines and Pharmaceutical Market revenue (US$ Million) by country, 2024-2031
8.4. Latin America
8.4.1. Latin America Glass Bottles and Vials for Vaccines and Pharmaceutical Market revenue (US$ Million) by Product Type, 2024-2031
8.4.2. Latin America Glass Bottles and Vials for Vaccines and Pharmaceutical Market revenue (US$ Million) by Application, 2024-2031
8.4.3. Latin America Glass Bottles and Vials for Vaccines and Pharmaceutical Market revenue (US$ Million) by End-user, 2024-2031
8.4.4. Latin America Glass Bottles and Vials for Vaccines and Pharmaceutical Market revenue (US$ Million) by country, 2024-2031
8.5. Middle East & Africa
8.5.1. Middle East & Africa Glass Bottles and Vials for Vaccines and Pharmaceutical Market revenue (US$ Million) by Product Type, 2024-2031
8.5.2. Middle East & Africa Glass Bottles and Vials for Vaccines and Pharmaceutical Market revenue (US$ Million) by Application, 2024-2031
8.5.3. Middle East & Africa Glass Bottles and Vials for Vaccines and Pharmaceutical Market revenue (US$ Million) by End-user, 2024-2031
8.5.4. Middle East & Africa Glass Bottles and Vials for Vaccines and Pharmaceutical Market revenue (US$ Million) by country, 2024-2031
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. SCHOTT AG
9.2.2. Thermo Fisher Scientific
9.2.3. ZHENGCHUAN ICP
9.2.4. Cang Zhou Four-star Glass Co., Ltd.
9.2.5. Stevanato Group P.IVA
9.2.6. Gerresheimer AG
9.2.7. SGD Pharma
9.2.8. Qorpak
9.2.9. Corning Incorporated
9.2.10. SM PACK
9.2.11. Other Prominent Players
By Product Type-
By Application-
By End-User
By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
